Rapt Therapeutics, Inc. (RAPT)
57.63
-0.01
(-0.02%)
USD |
NASDAQ |
Jan 23, 16:00
57.64
0.00 (0.00%)
After-Hours: 20:00
Rapt Therapeutics Research and Development Expense (TTM): 82.87M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.70B |
| Merck & Co., Inc. | 14.26B |
| Pfizer Inc. | 10.13B |
| Plus Therapeutics, Inc. | 7.624M |
| Geron Corp. | 81.32M |